Australia and Oceania: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Australia and Oceania

In 2022, the prophylactic medicaments containing insulin market in Australia and Oceania was finally on the rise to reach $X for the first time since 2019, thus ending a two-year declining trend. The market value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations being recorded in certain years. Over the period under review, the market attained the maximum level at $X in 2014; however, from 2015 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Australia and Oceania

In value terms, prophylactic medicaments containing insulin production dropped modestly to $X in 2022 estimated in export price. The total production indicated a buoyant increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2019 indices. The most prominent rate of growth was recorded in 2014 with an increase of X%. Over the period under review, production hit record highs at $X in 2019; however, from 2020 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Australia and Oceania

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported in Australia and Oceania contracted rapidly to X tons, with a decrease of X% on the year before. Over the period under review, exports saw a pronounced decline. The most prominent rate of growth was recorded in 2021 when exports increased by X%. Over the period under review, the exports hit record highs at X tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports declined notably to $X in 2022. In general, exports continue to indicate a abrupt curtailment. The most prominent rate of growth was recorded in 2018 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X. From 2019 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

Australia (X tons) represented roughly X% of total exports in 2022.

Australia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of X% from 2012 to 2022. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, Australia ($X) also remains the largest prophylactic medicaments containing insulin supplier in Australia and Oceania.

In Australia, prophylactic medicaments containing insulin exports decreased by an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in Australia and Oceania amounted to $X per ton, jumping by X% against the previous year. In general, the export price, however, recorded a relatively flat trend pattern. Over the period under review, the export prices hit record highs at $X per ton in 2018; however, from 2019 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Australia.

From 2012 to 2022, the rate of growth in terms of prices for Australia amounted to X% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Australia and Oceania

After two years of decline, purchases abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons in 2022. Overall, imports, however, showed a mild decrease. The pace of growth was the most pronounced in 2019 with an increase of X% against the previous year. The volume of import peaked at X tons in 2015; however, from 2016 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports soared to $X in 2022. The total import value increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The level of import peaked at $X in 2014; however, from 2015 to 2022, imports failed to regain momentum.

Imports by Country

Australia was the largest importing country with an import of around X tons, which amounted to X% of total imports. It was distantly followed by New Zealand (X tons), creating a X% share of total imports.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin imports into Australia stood at X%. At the same time, New Zealand (X%) displayed positive paces of growth. Moreover, New Zealand emerged as the fastest-growing importer imported in Australia and Oceania, with a CAGR of X% from 2012-2022. From 2012 to 2022, the share of New Zealand increased by X percentage points.

In value terms, Australia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Australia and Oceania, comprising X% of total imports. The second position in the ranking was held by New Zealand ($X), with a X% share of total imports.

From 2012 to 2022, the average annual growth rate of value in Australia was relatively modest.

Import Prices by Country

In 2022, the import price in Australia and Oceania amounted to $X per ton, dropping by X% against the previous year. Import price indicated a temperate expansion from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price increased by X% against 2020 indices. The pace of growth was the most pronounced in 2017 an increase of X% against the previous year. The level of import peaked at $X per ton in 2018; however, from 2019 to 2022, import prices stood at a somewhat lower figure.

Average prices varied noticeably amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was New Zealand ($X per ton), while Australia amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Australia (X%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :